EX-99.1 2 ea021216701ex99-1_silexion.htm JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K)(1)

Exhibit 1

 

JOINT FILING AGREEMENT

 

The undersigned parties hereby agree that this Statement on Schedule 13D filed herewith, and any amendments thereto filed hereafter by any of the undersigned parties, relating to the ordinary shares, par value $0.0001 per share of Silexion Therapeutics Corp, is being (and will be, in the case of amendments hereto) filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, on behalf of each such person.

 

Date: August 22, 2024

 

  GREENSTAR, L.P.
       
  By: Moringa Partners Ltd., its sole General Partner
       
    By: /s/ Ilan Levin
    Name:  Ilan Levin
    Title: Director
       
 

Moringa Sponsor, LP

       
  By: Moringa Partners Ltd., its sole General Partner
       
    By: /s/ Ilan Levin
    Name: Ilan Levin
    Title: Director
       
  Moringa Partners Ltd.
   
  /s/ Ilan Levin
  Ilan Levin
  Director
   
  /s/ Ilan Levin
 

ILAN LEVIN